Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial
- PMID: 24291366
- DOI: 10.1016/j.jhep.2013.11.019
Carvedilol vs. esophageal variceal band ligation in the primary prophylaxis of variceal hemorrhage: a multicentre randomized controlled trial
Abstract
Background & aims: Esophageal variceal bleed is a major problem in patients with cirrhosis. Endoscopic variceal ligation (EVL) has been shown to be equal to or better than propranolol in preventing first bleed. Carvedilol is a non-selective β blocker with alpha-1 adrenergic blocker activity. Hemodynamic studies have shown carvedilol to be more effective than propranolol at reducing portal pressure. We compared efficacy of carvedilol with EVL for primary prophylaxis of esophageal variceal bleed.
Methods: Cirrhotic patients with esophageal varices were randomized to carvedilol 12.5mg daily or EVL at three university hospitals of Pakistan. End points were esophageal variceal bleeding, death or liver transplant.
Results: Two hundred and nine patients were evaluated. Eighty two and eighty six patients were randomized in carvedilol and EVL arms respectively. Mean age was 48 ± 12.2 years; 122 (72.7%) were males; 89.9% had viral cirrhosis; mean Child-Pugh score was 7.3 ± 1.6 and mean follow up was 13.3 ± 12.1 months (range 1-50 months). Both EVL and carvedilol groups had comparable variceal bleeding rates (8.5% vs. 6.9%), bleed related mortality (4.6% vs. 4.9%) and overall mortality (12.8% vs. 19.5%) respectively. Adverse events in carvedilol group were hypotension (n=2), requiring cessation of therapy, while transient nausea (n=18) and dyspnea (n=30) resolved spontaneously. In the EVL arm, post banding ulcer bleed (n=1) and chest pain (n=17), were termed as serious adverse events while transient dysphagia (n=58) resolved without treatment.
Conclusions: Although our study is underpowered, the findings suggest that carvedilol is probably not superior to EVL in preventing first variceal bleed in patients with viral cirrhosis.
Keywords: Carvedilol; Cirrhosis; Endoscopic variceal ligation; Portal hypertension; Primary prophylaxis; Randomized controlled trial; Variceal hemorrhage.
Copyright © 2013 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
Similar articles
-
Randomized controlled trial of carvedilol versus variceal band ligation for the prevention of the first variceal bleed.Hepatology. 2009 Sep;50(3):825-33. doi: 10.1002/hep.23045. Hepatology. 2009. PMID: 19610055 Clinical Trial.
-
Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding.J Hepatol. 2014 Nov;61(5):1014-9. doi: 10.1016/j.jhep.2014.06.015. Epub 2014 Jun 19. J Hepatol. 2014. PMID: 24953021 Clinical Trial.
-
Endoscopic variceal ligation plus propranolol versus endoscopic variceal ligation alone in primary prophylaxis of variceal bleeding.Am J Gastroenterol. 2005 Apr;100(4):797-804. doi: 10.1111/j.1572-0241.2005.40468.x. Am J Gastroenterol. 2005. PMID: 15784021 Clinical Trial.
-
Primary prophylaxis of variceal bleeding.Clin Liver Dis. 2014 May;18(2):335-45. doi: 10.1016/j.cld.2013.12.005. Epub 2014 Feb 25. Clin Liver Dis. 2014. PMID: 24679498 Review.
-
Pharmacologic prevention of variceal bleeding and rebleeding.Hepatol Int. 2018 Feb;12(Suppl 1):68-80. doi: 10.1007/s12072-017-9833-y. Epub 2017 Dec 5. Hepatol Int. 2018. PMID: 29210030 Review.
Cited by
-
The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis.Patient Prefer Adherence. 2015 Jul 14;9:961-70. doi: 10.2147/PPA.S84762. eCollection 2015. Patient Prefer Adherence. 2015. PMID: 26203230 Free PMC article.
-
Varices and Variceal Hemorrhage in Cirrhosis: A New View of an Old Problem.Clin Gastroenterol Hepatol. 2015 Nov;13(12):2109-17. doi: 10.1016/j.cgh.2015.07.012. Epub 2015 Jul 17. Clin Gastroenterol Hepatol. 2015. PMID: 26192141 Free PMC article. Review.
-
Evaluation and Management of Esophageal and Gastric Varices in Patients with Cirrhosis.Clin Liver Dis. 2020 Aug;24(3):335-350. doi: 10.1016/j.cld.2020.04.011. Epub 2020 May 31. Clin Liver Dis. 2020. PMID: 32620275 Free PMC article. Review.
-
Beta-blockers in cirrhosis: Evidence-based indications and limitations.JHEP Rep. 2019 Dec 20;2(1):100063. doi: 10.1016/j.jhepr.2019.12.001. eCollection 2020 Feb. JHEP Rep. 2019. PMID: 32039404 Free PMC article. Review.
-
Management of Portal Hypertension in the Older Patient.Curr Gastroenterol Rep. 2024 Sep;26(9):231-240. doi: 10.1007/s11894-024-00930-y. Epub 2024 May 23. Curr Gastroenterol Rep. 2024. PMID: 38780678 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical